Remember Me
Or use your Academic/Social account:


Or use your Academic/Social account:


You have just completed your registration at OpenAire.

Before you can login to the site, you will need to activate your account. An e-mail will be sent to you with the proper instructions.


Please note that this site is currently undergoing Beta testing.
Any new content you create is not guaranteed to be present to the final version of the site upon release.

Thank you for your patience,
OpenAire Dev Team.

Close This Message


Verify Password:
Verify E-mail:
*All Fields Are Required.
Please Verify You Are Human:
fbtwitterlinkedinvimeoflicker grey 14rssslideshare1
Kuo, Chang‐Fu; Grainge, Matthew J.; Valdes, Ana M.; See, Lai‐Chu; Luo, Shue‐Fen; Yu, Kuang‐Hui; Zhang, Weiya; Doherty, Michael (2015)
Publisher: John Wiley and Sons Inc.
Journal: Arthritis & Rheumatology (Hoboken, N.j.)
Languages: English
Types: Article
Subjects: Sjögren's Syndrome
Objective: To investigate familial aggregation of Sjögren's syndrome (SS) and the relative risks (RRs) of other autoimmune disease in relatives of patients with SS. \ud Methods: We identified 23,658,577 beneficiaries enrolled in the Taiwan National Health Insurance system in 2010, of whom 12,754 had SS. We identified 21,009,551 parent–child relationships and 17,168,340 pairs of full siblings. The familial risks of SS and other autoimmune diseases, tetrachoric correlation, and familial transmission were estimated. \ud Results: We identified 105 patients with SS who had an affected first-degree relative. The RR of SS was 18.99 (95% confidence interval [95% CI] 9.76–36.93) in siblings of patients with SS, 11.31 (95% CI 8.34–15.33) in offspring, and 12.46 (95% CI 9.34–16.62) in parents. Tetrachoric correlation coefficients were 0.53 (95% CI 0.41–0.65) for cotwins of affected individuals and 0.21 (95% CI 0.16–0.26) for full siblings. The familial transmission (heritability plus shared environmental contribution) was 0.54 (95% CI 0.44–0.77). In first-degree relatives of patients with SS, the RRs were 2.95 (95% CI 2.33–3.73) for rheumatoid arthritis, 6.25 (95% CI 5.15–7.58) for systemic lupus erythematosus, 2.39 (95% CI 0.77–7.41) for systemic sclerosis, 0.71 (95% CI 0.10–5.07) for idiopathic inflammatory myopathy, 1.97 (95% CI 1.29–3.02) for type 1 diabetes mellitus, 3.38 (95% CI 1.26–9.05) for multiple sclerosis, 1.67 (95% CI 0.83–3.33) for myasthenia gravis, 1.25 (95% CI 1.04–1.50) for psoriasis, 1.21 (95% CI 0.39–3.76) for inflammatory bowel disease, and 2.29 (95% CI 1.19–4.40) for vasculitis. \ud Conclusion: The risk of SS and other autoimmune diseases is increased in relatives of patients with SS, and more than one-half of phenotypic variance in SS can be explained by familial factors.
  • The results below are discovered through our pilot algorithms. Let us know how we are doing!

    • 1. Fox RI. Sjogren's syndrome. Lancet 2005;366:321-31.
    • 2. Castro-Poltronieri A, Alarcon-Segovia D. Articular manifestations of primary Sjogren's syndrome. J Rheumatol 1983;10:485-8.
    • 3. Goules A, Masouridi S, Tzioufas AG, Ioannidis JP, Skopouli FN, Moutsopoulos HM. Clinically significant and biopsy-documented renal involvement in primary Sjogren syndrome. Medicine (Baltimore) 2000;79:241-9.
    • 4. Cornec D, Chiche L. Is primary Sjogren's syndrome an orphan disease? A critical appraisal of prevalence studies in Europe. Ann Rheum Dis 2015;74:e25.
    • 5. See LC, Kuo CF, Chou MJ, Yu KH. Sex- and age-specific incidence of autoimmune rheumatic diseases in the Chinese population: a Taiwan population-based study. Semin Arthritis Rheum 2013;43:381-6.
    • 6. Besana C, Salmaggi C, Pellegrino C, Pierro L, Vergani S, Faravelli A, et al. Chronic bilateral dacryo-adenitis in identical twins: a possible incomplete form of Sjogren syndrome. Eur J Pediatr 1991;150:652-5.
    • 7. Bolstad AI, Haga HJ, Wassmuth R, Jonsson R. Monozygotic twins with primary Sjogren's syndrome. J Rheumatol 2000;27:2264-6.
    • 8. Houghton KM, Cabral DA, Petty RE, Tucker LB. Primary Sjogren's syndrome in dizygotic adolescent twins: one case with lymphocytic interstitial pneumonia. J Rheumatol 2005;32:1603-6.
    • 9. Scofield RH, Kurien BT, Reichlin M. Immunologically restricted and inhibitory anti-Ro/SSA in monozygotic twins. Lupus 1997;6:395-8.
    • 10. Reveille JD, Wilson RW, Provost TT, Bias WB, Arnett FC. Primary Sjogren's syndrome and other autoimmune diseases in families: prevalence and immunogenetic studies in six kindreds. Ann Intern Med 1984;101:748-56.
    • 11. Lichtenfeld JL, Kirschner RH, Wiernik PH. Familial Sjogren's syndrome with associated primary salivary gland lymphoma. Am J Med 1976;60:286-92.
    • 12. Koivukangas T, Simila S, Heikkinen E, Rasanen O, WaszHockert O. Sjogren's syndrome and achalasia of the cardia in two siblings. Pediatrics 1973;51:943-5.
    • 13. Boling EP, Wen J, Reveille JD, Bias WB, Chused TM, Arnett FC. Primary Sjogren's syndrome and autoimmune hemolytic anemia in sisters: a family study. Am J Med 1983;74:1066-71.
    • 14. Sabio JM, Milla E, Jimenez-Alonso J. A multicase family with primary Sjogren's syndrome. J Rheumatol 2001;28:1932-4.
    • 15. Alarcon-Segovia D, Alarcon-Riquelme ME, Cardiel MH, Caeiro F, Massardo L, Villa AR, et al. Familial aggregation of systemic lupus erythematosus, rheumatoid arthritis, and other autoimmune diseases in 1,177 lupus patients from the GLADEL cohort. Arthritis Rheum 2005;52:1138-47.
    • 16. Priori R, Medda E, Conti F, Cassara EA, Sabbadini MG, Antonioli CM, et al. Risk factors for Sjogren's syndrome: a casecontrol study. Clin Exp Rheumatol 2007;25:378-84.
    • 17. Cruz-Tapias P, Rojas-Villarraga A, Maier-Moore S, Anaya JM. HLA and Sjogren's syndrome susceptibility: a meta-analysis of worldwide studies. Autoimmun Rev 2012;11:281-7.
    • 18. Miceli-Richard C, Comets E, Loiseau P, Puechal X, Hachulla E, Mariette X. Association of an IRF5 gene functional polymorphism with Sjogren's syndrome. Arthritis Rheum 2007;56:3989-94.
    • 19. Nordmark G, Kristjansdottir G, Theander E, Eriksson P, Brun JG, Wang C, et al. Additive effects of the major risk alleles of IRF5 and STAT4 in primary Sjogren's syndrome. Genes Immun 2009;10:68-76.
    • 20. Lessard CJ, Li H, Adrianto I, Ice JA, Rasmussen A, Grundahl KM, et al. Variants at multiple loci implicated in both innate and adaptive immune responses are associated with Sjogren's syndrome. Nat Genet 2013;45:1284-92.
    • 21. Li Y, Zhang K, Chen H, Sun F, Xu J, Wu Z, et al. A genome-wide association study in Han Chinese identifies a susceptibility locus for primary Sjogren's syndrome at 7q11.23. Nat Genet 2013;45:1361-5.
    • 22. Tzioufas AG, Kapsogeorgou EK, Moutsopoulos HM. Pathogenesis of Sjogren's syndrome: what we know and what we should learn. J Autoimmun 2012;39:4-8.
    • 23. National Health Insurance Administration. Ministry of Health and Welfare. The National Health Insurance Statistics, 2010. URL: http:// www.nhi.gov.tw/English/webdata/webdata.aspx?menu=11&menu_ id=296&webdata_id=1942&WD_ID=296.
    • 24. Kuo CF, Grainge MJ, See LC, Yu KH, Luo SF, Valdes AM, et al. Familial aggregation of gout and relative genetic and environmental contributions: a nationwide population study in Taiwan. Ann Rheum Dis 2015;74:369-74.
    • 25. Vitali C, Bombardieri S, Moutsopoulos HM, Balestrieri G, Bencivelli W, Bernstein RM, et al, the European Study Group on Diagnostic Criteria for Sjo€gren's Syndrome. Preliminary criteria for the classification of Sjo€gren's syndrome: results of a prospective concerted action supported by the European Community. Arthritis Rheum 1993;36:340-7.
    • 26. Vitali C, Bombardieri S, Jonsson R, Moutsopoulos HM, Alexander EL, Carsons SE, et al. Classification criteria for Sjogren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 2002;61:554-8.
    • 27. Liu CY, Huang YT, Chuang YL, Chen YJ, Weng WS, Liu JS, et al. Incorporating development stratification of Taiwan townships into sampling design of large scale health interview survey. J Health Manag 2006;14:1-22.
    • 28. Risch N. Linkage strategies for genetically complex traits. I. Multilocus models. Am J Hum Genet 1990;46:222-8.
    • 29. Chou CT, Pei L, Chang DM, Lee CF, Schumacher HR, Liang MH. Prevalence of rheumatic diseases in Taiwan: a population study of urban, suburban, rural differences. J Rheumatol 1994;21:302-6.
    • 30. Lee J, Chia KS. Estimation of prevalence rate ratios for cross sectional data: an example in occupational epidemiology. Br J Ind Med 1993;50:861-2.
    • 31. Lin DY. Cox regression analysis of multivariate failure time data: the marginal approach. Stat Med 1994;13:2233-47.
    • 32. Lichtenstein P, Yip BH, Bjork C, Pawitan Y, Cannon TD, Sullivan PF, et al. Common genetic determinants of schizophrenia and bipolar disorder in Swedish families: a population-based study. Lancet 2009;373:234-9.
    • 33. Falconer DS. The inheritance of liability to diseases with variable age of onset, with particular reference to diabetes mellitus. Ann Hum Genet 1967;31:1-20.
    • 34. Reich T, James JW, Morris CA. The use of multiple thresholds in determining the mode of transmission of semi-continuous traits. Ann Hum Genet 1972;36:163-84.
    • 35. Reich T, Rice J, Cloninger CR, Wette R, James J. The use of multiple thresholds and segregation analysis in analyzing the phenotypic heterogeneity of multifactorial traits. Ann Hum Genet 1979;42:371-90.
    • 36. Yang J, Visscher PM, Wray NR. Sporadic cases are the norm for complex disease. Eur J Hum Genet 2010;18:1039-43.
    • 37. Mason AM, Golding PL. Multiple immunological abnormalities in a family. J Clin Pathol 1971;24:732-5.
    • 38. Sestak AL, Shaver TS, Moser KL, Neas BR, Harley JB. Familial aggregation of lupus and autoimmunity in an unusual multiplex pedigree. J Rheumatol 1999;26:1495-9.
    • 39. Radstake TR, Barrera P, Albers JM, Swinkels HL, van de Putte LB, van Riel PL. Familial vs sporadic rheumatoid arthritis (RA): a prospective study in an early RA inception cohort. Rheumatology (Oxford) 2000;39:267-73.
    • 40. Sestak AL, Nath SK, Kelly JA, Bruner GR, James JA, Harley JB. Patients with familial and sporadic onset SLE have similar clinical profiles but vary profoundly by race. Lupus 2008;17:1004-9.
    • 41. Burbelo PD, Ambatipudi K, Alevizos I. Genome-wide association studies in Sjogren's syndrome: what do the genes tell us about disease pathogenesis? Autoimmun Rev 2014;13:756-61.
    • 42. Vyse TJ, Todd JA. Genetic analysis of autoimmune disease. Cell 1996;85:311-8.
    • 43. Smyth DJ, Cooper JD, Bailey R, Field S, Burren O, Smink LJ, et al. A genome-wide association study of nonsynonymous SNPs identifies a type 1 diabetes locus in the interferon-induced helicase (IFIH1) region. Nat Genet 2006;38:617-9.
    • 44. Stahl EA, Raychaudhuri S, Remmers EF, Xie G, Eyre S, Thomson BP, et al. Genome-wide association study metaanalysis identifies seven new rheumatoid arthritis risk loci. Nat Genet 2010;42:508-14.
    • 45. Hom G, Graham RR, Modrek B, Taylor KE, Ortmann W, Garnier S, et al. Association of systemic lupus erythematosus with C8orf13-BLK and ITGAM-ITGAX. N Engl J Med 2008; 358:900-9.
    • 46. Inoue N, Harada S, Miyasaka N, Oya A, Yanagi K. Analysis of antibody titers to Epstein-Barr virus nuclear antigens in sera of patients with Sjogren's syndrome and with rheumatoid arthritis. J Infect Dis 1991;164:22-8.
    • 47. Binder A, Maddison PJ, Skinner P, Kurtz A, Isenberg DA. Sjogren's syndrome: association with type-1 diabetes mellitus. Br J Rheumatol 1989;28:518-20.
    • 48. McGuire HM, Vogelzang A, Ma CS, Hughes WE, Silveira PA, Tangye SG, et al. A subset of interleukin-211 chemokine receptor CCR91 T helper cells target accessory organs of the digestive system in autoimmunity. Immunity 2011;34:602-15.
    • 49. De Seze J, Devos D, Castelnovo G, Labauge P, Dubucquoi S, Stojkovic T, et al. The prevalence of Sjogren syndrome in patients with primary progressive multiple sclerosis. Neurology 2001;57:1359-63.
    • 50. Tsokos M, Lazarou SA, Moutsopoulos HM. Vasculitis in primary Sjogren's syndrome: histologic classification and clinical presentation. Am J Clin Pathol 1987;88:26-31.
  • No related research data.
  • No similar publications.

Share - Bookmark

Cite this article